Concepedia

Misako Nagasaka

MN

83

Publications

3.8K

Citations

32

H-Index

2016

Active since

Affiliations

The Barbara Ann Karmanos Cancer Institute(Current)

University of California, Irvine

Wayne State University

St. Marianna University School of Medicine

Memorial Sloan Kettering Cancer Center

Misako Nagasaka is an author at The Barbara Ann Karmanos Cancer Institute specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2025

83

Publications

83

Trastuzumab Deruxtecan in <i>HER2</i> -Mutant Non–Small-Cell Lung Cancer

Bob T. Li, Egbert F. Smit, Yasushi Goto et al. · New England Journal of Medicine · 2021 · 886 citations · Full text

Repotrectinib in <i>ROS1</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, D. Ross Camidge, Sang‐We Kim et al. · New England Journal of Medicine · 2024 · 178 citations · Full text

Comprehensive pan-cancer genomic landscape of KRAS altered cancers and real-world outcomes in solid tumors

Jessica Lee, Smruthy Sivakumar, Alexa B. Schrock et al. · npj Precision Oncology · 2022 · 140 citations · Full text

Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial

Egbert F. Smit, Enriqueta Felip, Dipesh Uprety et al. · The Lancet Oncology · 2024 · 123 citations · Full text

, , +9

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients with HER2-mutated metastatic non-small cell lung cancer (NSCLC): Interim results of DESTINY-Lung01.

Egbert F. Smit, Kazuhiko Nakagawa, Misako Nagasaka et al. · Journal of Clinical Oncology · 2020 · 118 citations

, , +20

Rows per page

1–5 of 83